Prolonged inductive effect of rifampicin on linezolid exposure

European Journal of Clinical Pharmacology

Volumn 71, Issue 5, 2015, Pages 643-644

  Gervasoni, Cristina ^a   Simonetti, Francesco R ^a   Resnati, Chiara ^a   Charbe, Nitin ^a   Clementi, Emilio ^a,b   Cattaneo, Dario ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SCIENTIFIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; LINEZOLID; RIFAMPICIN;

CASE REPORT; CUTANEOUS FISTULA; DRUG ADMINISTRATION; DRUG INTERACTION; HUMAN; MALE; MICROBIOLOGY; OSTEOMYELITIS; TIME; YOUNG ADULT;

ANTI-BACTERIAL AGENTS; CUTANEOUS FISTULA; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; HUMANS; LINEZOLID; MALE; OSTEOMYELITIS; RIFAMPIN; TIME FACTORS; YOUNG ADULT;

EID: 84939962468     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-015-1833-z     Document Type: Letter

References (10)

1. Gebhart BC, Barker BC, Markewitz BA (2007) Decreased serum linezolid levels in a critically ill patient receiving concomitant linezolid and rifampin. Pharmacotherapy 27:476-479
2. Hoyo I, Martínez-Pastor J, Garcia-Ramiro S, Climent C, Brunet M, Cuesta M et al (2012) Decreased serum linezolid concentrations in two patients receiving linezolid and rifampicin due to bone infections. Scand J Infect Dis 44:548-50
3. Soriano A, Ortega M, García S, Peñarroja G, Bové A, Marcos M et al (2007) Comparative study of the effects of pyridoxine, rifampin, and renal function on hematological adverse events induced by linezolid. Antimicrob Agents Chemother 51:2559-63
4. Gandelman K, Zhu T, Fahmi OA, Glue P, Lian K, Obach RS et al (2011) Unexpected effect of rifampin on the pharmacokinetics of linezolid: in silico and in vitro approaches to explain its mechanism. J Clin Pharmacol 51:229-36
5. Egle H, Trittler R, Kümmerer K, Lemmen SW (2005) Linezolid and rifampin: drug interaction contrary to expectations? Clin Pharmacol Ther 77:451-3
6. Reitman ML, Chu X, Cai X, Yabut J, Venkatasubramanian R, Zajic S et al (2011) Rifampin's acute inhibitory and chronic inductive drug interactions: experimental and model-based approaches to drug-drug interaction trial design. Clin Pharmacol Ther 89:234-42
7. Horn JR, Hansten, PD (2011). Time course for enzyme induction and deinduction. http://www.pharmacytimes.com/publications/issue/2011/April2011/DrugInteractions-0411
8. Pea F, Viale P, Cojutti P, Del Pin B, Zamparini E, Furlanut M (2012) Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients. J Antimicrob Chemother 67:2034-42
9. Cattaneo D, Orlando G, Cozzi V, Cordier L, Baldelli S, Merli S et al (2013) Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with gram-positive infections. Int J Antimicrob Agents 41:586-9
10. Dong HY, Xie J, Chen LH, Wang TT, Zhao YR, Dong YL (2014) Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients. Eur J Clin Microbiol Infect Dis 33:1029-35